Neuralgic amyotrophy: An update in evaluation, diagnosis, and treatment approaches
- PMID: 39402917
- DOI: 10.1002/mus.28274
Neuralgic amyotrophy: An update in evaluation, diagnosis, and treatment approaches
Abstract
Neuralgic amyotrophy (NA) is an underrecognized peripheral nerve disorder distinguished by severe pain followed by weakness in the distribution of one or more nerves, most commonly in the upper extremity. While classically felt to carry a favorable prognosis, updates in research have demonstrated that patients frequently endure delay in diagnosis and continue to experience long term pain, paresis, and fatigue even years after the diagnosis is made. A transition in therapeutic approach is recommended and described by this review, which emphasizes the necessity to target compensatory abnormal motor control and fatigue by focusing on motor coordination, energy conservation strategies, and behavioral change, rather than strength training which may worsen the symptoms. The development of structural hourglass-like constrictions (HGCs) on imaging can help confirm the suspected clinical diagnosis, and in association with persistent weakness and limited recovery on electrodiagnostic testing may be considered for surgical consultation. Given the complex nature of management, a multidisciplinary approach is described, which can provide an optimal level of care and support for patients with persistent symptoms from NA and allow more unified guidance of rehabilitation and surgical referrals.
Keywords: brachial neuritis; neuralgic amyotrophy; parsonage‐turner syndrome; peripheral nerve; rehabilitation.
© 2024 Wiley Periodicals LLC.
References
REFERENCES
-
- van Alfen N, van Eijk JJJ, Ennik T, et al. Incidence of neuralgic amyotrophy (parsonage turner syndrome) in a primary care setting – a prospective cohort study. PLoS One. 2015;10(5):e0128361.
-
- JIJ, Janssen RMJ, van Alfen N. Neuralgic amyotrophy. Curr Opin Neurol. 2021;34(5):605‐612.
-
- van Alfen N, van Engelen BG. The clinical spectrum of neuralgic amyotrophy in 246 cases. Brain. 2006;129(2):438‐450.
-
- van Alfen N, van der Werf SP, van Engelen BG. Long‐term pain, fatigue, and impairment in neuralgic amyotrophy. Arch Phys Med Rehabil. 2009;90(3):435‐439.
-
- Kuhlenbaumer G et al. Mutations in SEPT9 cause hereditary neuralgic amyotrophy. Nat Genet. 2005;37(10):1044‐1046.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
